world. As of today, Japanese oncology professionals represent the 6th largest membership group within ESMO membership; with 286 abstracts submitted and 595 congress attendees, the Japanese oncology community significantly contributed to the success of the last ESMO 2014 Congress in Madrid. Being the official journal of both societies, Annals of Oncology, now ranked in the top 20 journals in the Science Citation Index, dramatically contributed to the dissemination of oncology knowledge and contributes to knowledge sharing between the European and Asian oncology community. The 2015 nomination of an ESMO National Representative for Japan is a further step to ensure that the voice of the Japanese oncology community is heard at a European level and that the two societies can actively collaborate on joint international research initiatives such as the "ESMO-led Global Opioid Initiative" and the "ESMO International Consortium study on the Availability of Anti-neoplastic Medicines".
